During the past decade, Yuncheng Central Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yuncheng Central Hospital" #1 sponsor was "AIM Vaccine Co., Ltd." with 1 trials, followed by "Bayer" with 1 trials sponsored, "CSPC ZhongQi Pharmaceutical Technology Co., Ltd." with 1 trials sponsored, "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored and "Institute of Hematology & Blood Diseases Hospital" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yuncheng Central Hospital" #1 collaborator was "Yuncheng Central Hospital" with 2 trials as a collaborator, "Cangzhou Central Hospital" with 1 trials as a collaborator, "Daqing Oil Field Hospital" with 1 trials as a collaborator, "Guangdong Provincial People's Hospital" with 1 trials as a collaborator and "Henan Cancer Hospital" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Yuncheng Central Hospital" are "Coronary Artery Disease" (2 trials), "Adverse Drug Events" (1 trials), "Adverse Drug Reactions" (1 trials), "Atrial Fibrillation" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Yuncheng Central Hospital" in a lesser frequency.

Most popular intervention types in "Yuncheng Central Hospital" are "Drug" (10 trials), "Biological" (2 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Antihypertensive Agents" (1 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yuncheng Central Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Yuncheng Central Hospital". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Yuncheng Central Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yuncheng Central Hospital, 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".